Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia

被引：1

作者：

Liansheng Zhao ^{[1
,2
]}

Huijuan Wang ^{[3
]}

Yamin Zhang ^{[1
,2
]}

Jinxue Wei ^{[1
,2
]}

Peiyan Ni ^{[1
,2
]}

Hongyan Ren ^{[1
,2
]}

Gang Li ^{[4
]}

Qiang Wang ^{[1
,2
]}

Gavin P Reynolds ^{[5
]}

Weihua Yue ^{[6
,7
]}

Wei Deng ^{[1
,2
]}

Hao Yan ^{[6
,7
]}

Liwen Tan ^{[8
]}

Qi Chen ^{[9
]}

Guigang Yang ^{[10
]}

Tianlan Lu ^{[6
,7
]}

Lifang Wang ^{[6
,7
]}

Fuquan Zhang ^{[11
]}

Jianli Yang ^{[12
,13
]}

Keqing Li ^{[14
]}

Luxian Lv ^{[15
]}

Qingrong Tan ^{[16
]}

Yinfei Li ^{[1
,2
]}

Hua Yu ^{[1
,2
]}

Hongyan Zhang ^{[6
,7
]}

Xin Ma ^{[9
]}

Fude Yang ^{[10
]}

Lingjiang Li ^{[8
]}

Chuanyue Wang ^{[9
]}

Huiyao Wang ^{[1
,2
]}

Xiaojing Li ^{[1
,2
]}

Wanjun Guo ^{[1
,2
]}

Xun Hu ^{[17
]}

Yang Tian ^{[1
,2
]}

Xiaohong Ma ^{[1
,2
]}

Jeremy Coid ^{[1
,2
]}

Dai Zhang ^{[6
,7
]}

Chao Chen ^{[3
]}

Tao Li ^{[1
,2
]}

机构：

[1] Beijing Hui Long Guan Hospital

[2] Wuxi Mental Health Center, Nanjing Medical University

[3] Institute of Mental Health, Tianjin Anding Hospital

[4] Tianjin Medical University General Hospital, Tianjin Medical University

[5] Hebei Mental Health Center

[6] Second Affiliated Hospital of Xinxiang Medical University

[7] Department of Psychiatry, Xijing Hospital, Fourth Military Medical University

[8] Huaxi Biobank, West China Hospital of Sichuan University

[9] Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University

[10] West China Brain Research Center, West China Hospital of Sichuan University

[11] The National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University

[12] Shaanxi Lifegen Co., Ltd

[13] Biomolecular Science Research Centre, Sheffield Hallam University

[14] Peking University Sixth Hospital(Institute of Mental Health)

[15] National Clinical Research Center for Mental Disorders and Key Laboratory of Mental Health, Ministry of Health(Peking University)

[16] Second Xiangya Hospital, Central South University

[17] Beijing Anding Hospital, Beijing Institute for Brain Disorders, Capital Medical University

来源：

NeuroscienceBulletin | 2019年 / 35卷 / 06期

基金：

中国国家自然科学基金;

关键词：

Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia;

D O I：

暂无

中图分类号：

R749.3 [精神分裂症];

学科分类号：

摘要：

Dear Editor,Schizophrenia is a chronic and debilitating brain disorder,which has a strong genetic component with heritability ranging from 66%to 85%[1, 2]. Currently, antipsychotic drugs remain the most effective treatment for the psychotic

引用

页码：1102 / 1105

页数：4

共 50 条

[41] Lack of association between two dopamine D2 receptor gene polymorphisms and schizophrenia
Caprini, Sara
Saetre, Peter
Melle, Ingrid
Djurovic, Srdjan
Andreassen, Ole A.
Skjodt, Celina
Duong, Linh
Werge, Thomas
Hall, Hakan
Agartz, Ingrid
Terenius, Lars
Jonsson, Erik G.
PSYCHIATRIC GENETICS, 2011, 21 (04) : 214 - 215
[42] The dopamine receptor D2 genotype is associated with hyperprolactinemia
Hansen, KA
Zhang, YY
Colver, R
Tho, SPT
Plouffe, L
McDonough, PG
FERTILITY AND STERILITY, 2005, 84 (03) : 711 - 718
[43] Interaction of the dopamine D2 receptor and endogenous β-arrestin 1 and 2
Macey, TA
Neve, KA
FASEB JOURNAL, 2003, 17 (04): : A638 - A638
[44] Efficacy and safety of D2 partial agonists in the treatment of schizophrenia - the short-term perspective
Mattingly, G.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S629 - S630
[45] Preferential interaction between the dopamine D2 receptor and arrestin2 in neostriatal neurons
Macey, TA
Gurevich, VV
Neve, KA
MOLECULAR PHARMACOLOGY, 2004, 66 (06) : 1635 - 1642
[46] Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
Adrian Newman-Tancredi
Mark S. Kleven
Psychopharmacology, 2011, 216 : 451 - 473
[47] Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa
Bailer, Ursula F.
Frank, Guido K.
Price, Julie C.
Meltzer, Carolyn C.
Becker, Carl
Mathis, Chester A.
Wagner, Angela
Barbarich-Marsteller, Nicole C.
Bloss, Cinnamon S.
Putnam, Karen
Schork, Nicholas J.
Gamst, Anthony
Kaye, Walter H.
PSYCHIATRY RESEARCH-NEUROIMAGING, 2013, 211 (02) : 160 - 168
[48] Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking
Luykx, Jurjen J.
Tanskanen, Antti
Lahteenvuo, Markku
Manu, Peter
Correll, Christoph U.
Hasan, Alkomiet
Lieslehto, Johannes
Taipale, Heidi
Tiihonen, Jari
PSYCHIATRY RESEARCH, 2024, 339
[49] Dopamine D2, serotonin 2A, and 2C receptor polymorphisms in afrocaribbean inpatients: Differences in association with parkinsonism, tremor, and rigidity
Al Hadithy, A. F. Y.
Wilffert, B.
Stewart, R. E.
Looman, N. M. G.
Bruggeman, R.
Brouwers, J. R. B. J.
Matrons, G. E.
van Os, J.
Hoek, H. W.
van Harten, P. N.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 104 - 104
[50] Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
Newman-Tancredi, Adrian
Kleven, Mark S.
PSYCHOPHARMACOLOGY, 2011, 216 (04) : 451 - 473

← 1 2 3 4 5 →